Table 1.
Characteristics of the development cohort at the time of transplantation
| Recipient Characteristics | Value | N |
|---|---|---|
| Age (yr), mean±SD | 278 | 47.3±14.7 |
| Male sex, n (%) | 278 | 149 (53.6) |
| Retransplantation, n (%) | 278 | 89 (32.0) |
| Pre-emptive transplantation, n (%) | 278 | 34 (12.2) |
| Time since dialysis (yr), mean±SD | 244 | 5.4±5.3 |
| Blood type, n (%) | 278 | |
| A | 121 (43.5) | |
| B | 34 (12.2) | |
| O | 112 (40.3) | |
| AB | 11 (4.0) | |
| CKD, n (%) | 278 | |
| Glomerulopathy | 83 (29.8) | |
| Vascular nephropathy | 22 (7.9) | |
| Chronic interstitial nephropathy | 30 (10.8) | |
| Malformative uropathy | 16 (5.8) | |
| Polycystic kidney disease | 19 (6.8) | |
| Diabetes | 27 (9.7) | |
| Other | 16 (5.8) | |
| Not determined | 65 (23.4) | |
| Donor characteristics | ||
| Age (yr), mean±SD | 278 | 50.7±17.8 |
| Male sex, n (%) | 278 | 150 (54.0) |
| Type, n (%) | 278 | |
| Living | 42 (15.1) | |
| Cerebrovascular death | 108 (38.9) | |
| Other cause of death | 128 (46.0) | |
| Terminal serum creatinine (µmol/L), mean±SD | 278 | 91.5±54.0 |
| Transplant characteristics | ||
| Cold ischemia time (h), mean±SD | 278 | 17.0±9.4 |
| HLA mismatch, mean±SD | 278 | |
| A | 1.1±0.6 | |
| B | 1.4±0.7 | |
| DR | 1.1±0.6 | |
| Anti-HLA DSA at the time of transplantation, n (%) | 278 | 102 (36.7) |